Chenyi Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chenyi Jiang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Benchi Che
Department of Orthopaedics, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Binyu Chen
Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
1 shared publication- Biyu Rui
Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Chao Zhang
Department of Orthopaedics, Shanghai Sixth People’s Hospital Fujian Campus
1 shared publication- Chunyang Wang
Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Chu’an Gao
Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
1 shared publication
Latest Publications
- 13 October 2026
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
Clinical Practice Guideline of Surgical Treatment of Segmental Bone Defects After Open Tibia Diaphyseal Fracture
Purpose: Segmental tibial diaphyseal bone defects after open fracture are difficult to treat and require timely, coordinated reconstruction. We aimed to develop evidence-based surgical guidelines based on meta-analysis and consensus recommendations from an expert committee of orthopedic surgeons. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, we searched 5 databases (1989 to 2024) for studies evaluating surgical treatment of post-traumatic tibial diaphyseal segmental defects. Random-effects models pooled union rate, union time, and complication rate across 4 techniques (Ilizarov bone transport [IBT], free vascularized bone grafting [FVBG], nonvascularized autografting [AG], and the Masquelet technique [MT]). Consensus recommendations were developed using a Delphi process. Results: Twenty-eight studies, including 824 patients (824 tibias) were analyzed: IBT (11 studies; n=361), FVBG (4; n=68), AG (10; n=164), and MT (6; n=67). Pooled union rates were 96% (IBT), 95% (FVBG), 95% (AG), and 81% (MT). Mean pooled union times were 33.04 weeks (IBT), 37.81 (FVBG), 29.73 (AG), and 29.74 (MT). Pooled complication rates were 82% (IBT), 94% (FVBG), 44% (AG), and 53% (MT). Conclusion: On the basis of the evidence and expert consensus, early operative management with prompt stabilization and antimicrobial therapy, supported by multidisciplinary care, is recommended. For large or complex defects, IBT and FVBG are generally preferred, while AG and MT remain options in selected scenarios. Outcomes depend on early intervention, appropriate technique selection, and structured rehabilitation; further high-quality studies are needed to validate these recommendations.
- 13 October 2026
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
Clinical Practice Guideline of Surgical Treatment of Segmental Bone Defects After Open Tibia Diaphyseal Fracture
Purpose: Segmental tibial diaphyseal bone defects after open fracture are difficult to treat and require timely, coordinated reconstruction. We aimed to develop evidence-based surgical guidelines based on meta-analysis and consensus recommendations from an expert committee of orthopedic surgeons. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, we searched 5 databases (1989 to 2024) for studies evaluating surgical treatment of post-traumatic tibial diaphyseal segmental defects. Random-effects models pooled union rate, union time, and complication rate across 4 techniques (Ilizarov bone transport [IBT], free vascularized bone grafting [FVBG], nonvascularized autografting [AG], and the Masquelet technique [MT]). Consensus recommendations were developed using a Delphi process. Results: Twenty-eight studies, including 824 patients (824 tibias) were analyzed: IBT (11 studies; n=361), FVBG (4; n=68), AG (10; n=164), and MT (6; n=67). Pooled union rates were 96% (IBT), 95% (FVBG), 95% (AG), and 81% (MT). Mean pooled union times were 33.04 weeks (IBT), 37.81 (FVBG), 29.73 (AG), and 29.74 (MT). Pooled complication rates were 82% (IBT), 94% (FVBG), 44% (AG), and 53% (MT). Conclusion: On the basis of the evidence and expert consensus, early operative management with prompt stabilization and antimicrobial therapy, supported by multidisciplinary care, is recommended. For large or complex defects, IBT and FVBG are generally preferred, while AG and MT remain options in selected scenarios. Outcomes depend on early intervention, appropriate technique selection, and structured rehabilitation; further high-quality studies are needed to validate these recommendations.
- Open Access
- 27 September 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
Osteosarcopenia and stability of fragility pelvic fractures in elderly women
- 27 September 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
Open AccessOsteosarcopenia and stability of fragility pelvic fractures in elderly women
- Open Access
Global burden of musculoskeletal disorders in postmenopausal women across 204 countries and territories: a systematic analysis of the 2021 Global Burden of Disease Study with projections to 2050
Objective This study aimed to systematically analyze the epidemiological characteristics of six major musculoskeletal disorders (MSDs) among postmenopausal women globally from 1990 to 2021, with a focus on the spatiotemporal distribution patterns of disease prevalence and associated disability-adjusted life years (DALYs). Methods Utilizing the 2021 Global Burden of Disease (GBD) database, we examined six MSDs in postmenopausal women: rheumatoid arthritis, osteoarthritis, low back pain, neck pain, gout, and other musculoskeletal disorders. Age-standardized rates (ASRs) were calculated using internationally recognized methods, and estimated annual percentage changes (EAPCs) were employed to assess temporal trends in disease burden. The analysis incorporated considerations of age structure, sociodemographic index (SDI), and various risk factors. Results From 1990 to 2021, the global burden of MSDs among postmenopausal women showed a persistent increase, with marked heterogeneity across disease subtypes and geographical regions. Osteoarthritis represented the predominant disease burden, while gout exhibited the most rapid growth despite its lower baseline prevalence. Notably, low back pain was the only subtype demonstrating a declining trend. The burden of MSDs shifted from high-SDI regions to developing areas, with middle-SDI countries emerging as new priorities for intervention. Older age groups bore a disproportionately high disease burden, and obesity was identified as the leading risk factor driving disease progression, whereas tobacco control measures showed positive effects. Projections indicated that MSD burden will continue to rise with population aging, necessitating tailored prevention and management strategies to address this major public health challenge. Conclusion The prevalence of MSDs among postmenopausal women continues to rise, underscoring its profound impact on global health in aging female populations. To address this challenge, a multidimensional intervention approach is required, including: (1) enhanced early screening and standardized management of MSD-related risk factors; (2) personalized lifestyle interventions based on individual BMI levels; and (3) implementation of differentiated public health policies tailored to population-specific characteristics. The comprehensive adoption of these measures will help improve musculoskeletal health in postmenopausal women and reduce the overall disease burden attributable to MSDs.
Open AccessGlobal burden of musculoskeletal disorders in postmenopausal women across 204 countries and territories: a systematic analysis of the 2021 Global Burden of Disease Study with projections to 2050
Objective This study aimed to systematically analyze the epidemiological characteristics of six major musculoskeletal disorders (MSDs) among postmenopausal women globally from 1990 to 2021, with a focus on the spatiotemporal distribution patterns of disease prevalence and associated disability-adjusted life years (DALYs). Methods Utilizing the 2021 Global Burden of Disease (GBD) database, we examined six MSDs in postmenopausal women: rheumatoid arthritis, osteoarthritis, low back pain, neck pain, gout, and other musculoskeletal disorders. Age-standardized rates (ASRs) were calculated using internationally recognized methods, and estimated annual percentage changes (EAPCs) were employed to assess temporal trends in disease burden. The analysis incorporated considerations of age structure, sociodemographic index (SDI), and various risk factors. Results From 1990 to 2021, the global burden of MSDs among postmenopausal women showed a persistent increase, with marked heterogeneity across disease subtypes and geographical regions. Osteoarthritis represented the predominant disease burden, while gout exhibited the most rapid growth despite its lower baseline prevalence. Notably, low back pain was the only subtype demonstrating a declining trend. The burden of MSDs shifted from high-SDI regions to developing areas, with middle-SDI countries emerging as new priorities for intervention. Older age groups bore a disproportionately high disease burden, and obesity was identified as the leading risk factor driving disease progression, whereas tobacco control measures showed positive effects. Projections indicated that MSD burden will continue to rise with population aging, necessitating tailored prevention and management strategies to address this major public health challenge. Conclusion The prevalence of MSDs among postmenopausal women continues to rise, underscoring its profound impact on global health in aging female populations. To address this challenge, a multidimensional intervention approach is required, including: (1) enhanced early screening and standardized management of MSD-related risk factors; (2) personalized lifestyle interventions based on individual BMI levels; and (3) implementation of differentiated public health policies tailored to population-specific characteristics. The comprehensive adoption of these measures will help improve musculoskeletal health in postmenopausal women and reduce the overall disease burden attributable to MSDs.